Wednesday 21 April 2021
Home      All news      Contact us      RSS      India
business-standard - 13 days ago

Cadila gains on receiving final USFDA nod for Macitentan Tablets

Cadila Healthcare rose 1.03% to Rs 466 after the pharma company announced that it has received final approval from the USFDA to market Macitentan Tablets, 10 mg.


Latest News
Hashtags:   

Cadila

 | 

gains

 | 

receiving

 | 

final

 | 

USFDA

 | 

Macitentan

 | 

Tablets

 | 

Sources